Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1992-08-05
2000-05-02
Bernhardt, Emily
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
544244, C07F 96512, A61K 31675
Patent
active
060573058
ABSTRACT:
Resolved enantiomers of the formula ##STR1## wherein B is a purine or pyrimidine base or aza and/or deaza analogs thereof are useful in antiviral pharmaceutical compositions to treat retroviral infections.
REFERENCES:
patent: 4659825 (1987-04-01), Holy et al.
patent: 4724233 (1988-02-01), De Clercq et al.
patent: 4808716 (1989-02-01), Holy et al.
patent: 5130427 (1992-07-01), Alexander et al.
patent: 5142051 (1992-08-01), Holy et al.
patent: 5302585 (1994-04-01), Yu et al.
patent: 5466806 (1995-11-01), Belleau et al.
patent: 5650510 (1997-07-01), Webb, II et al.
Internal Medicine (4th Ed.), Jay H. Stein, Editor-in-Chief, pp 600-601, 2047 (1994).
Organic Chemistry by Paul Karrer (2nd Ed.), pp 92-102 (1946).
Balzarini et al, "Activity of the (R)-Enantiomers of 9-(2-Phosphonylmethoxypropyl)-Adenine and 9-(2-Phosphonylmethoxypropyl)-2,6-diaminopurine against Human Immunodeficiency Virus in Different Human Cell Systems," Biochem Biophys Res Comm 219:337-341 (1996).
Gilson et al., "A Placebo-Controlled Phase I/II Study of Adefovir Dipivoxil (Bis-Pom PMEA) in Patients with Chronic Hepatitis B Infection," American Association for the Study of Liver Diseases Abstract (Nov. 8-12, 1996).
Koszalka et al, "Inhibition of HIV- and HBV-Virus Replication By 2,6-Disubstituted Purine 2',3'-Dideoxynucleosides," Poster (Apr. 1995).
Vince et al., "6-Substituted Derivatives of Carbovir: Anti-HIV Activity," Nucls & Nuclt 14(8):1703-1708 (1995).
,Fields, Virology, 2nd ed., vol. 2, pp. 1439, 1449,-1450, 2137-2139, 2151 (Raven Press, Ltd., 1990).
Cohen, John, "New Drug Shows Promise in Monkeys," Science 270:1121-1122 (Nov. 17, 1995).
De Clercq et al., "Efficacy of Phosphonylmethoxyalkyl Derivatives of Adenine in Experimental Herpes Simplex Virus and Vaccinia Virus Infections in Vivo," Antimicro AG & Chemo 33(2):185-191 (1989).
Dvorakova et al, "Synthesis and Antiviral Activity of Acyclic Nucleoside and Nucleotide Derivatives of 8-Azaadenine," Collect Czech Chem Commun 58:253-255 (1993).
Greene et al., Protective Groups in Organic Synthesis (2nd Ed.) (John Wiley & Sons), p. 362, 364-367 (1991).
Holy et al, "Antiviral Activity of 2-Phosphonomethoxyalkyl Derivatives of N6-Substituted 6-Aminopurines," 8th International Conference on Antiviral Research, Santa Fe, NM 26(3):A231 (1995).
Hudlicky, Reductions in Organic Chemistry, pp. 76, 92-96 (1984).
Kim et al, "A new class of acyclic phosphonate nucleotide analogues: phosphonate isosteres of acyclovir and ganciclovir monophosphates as antiviral agents," J Med Chem 34(7):2286-2294 (1991).
Tsai et al., "Prevention of SIV Infection in Macaques by (R)-9-(2-Phosphonylmethoxypropyl)adenine," Science 270:1197-1199 (Nov. 17, 1995).
Vahlenkamp et al., "(R)-9-(2-Phosphonylmethoxypropyl)-2,6-Diaminopurine Is a Potent Inhibitor of Feline Immunodeficiency Virus Infection," Antimicro AG & Chemo 39(3):746-749 (1995).
Yokota et al, "Inhibitory effects of acyclic nucleoside phosphonate analogues on hepatitis B virus DNA synthesis in HB611 cells," Antiviral Chem & Chemo 5(2):57-63 (1994).
anon., Antiviral Agents Bulletin, 8(11):325-326 (1995).
Clayette et al, "Anti-HIV activities of novel nucleoside analogues", Antiviral Chemistry & Chemotherapy, 2(6):329-336 (1991).
Colla et al, "Synthesis of aliphatic nucleoside analogues with potential antiviral activity", Eur. J. Med. Chem.--Chim. Ther., 17:569-576 (1982).
Schaeffer et al, "Enzyme Inhibitors. VIII. Studies on the Mode of Binding of Some 6-Substituted 9-(Hydroxyalkyl)purines to Adenosine Deaminase", Journal of Medicinal Chemistry, 8(4):502-506 (1965).
Sugawara et al, "Stereoselective Synthesis of 1- and 2-0-alpha-D-Cellotriosyl-3-deoxy-2(R)-and 2(S)-glycerols Related to Rhynchosporoside", Agricultural and Biological Chemistry, 50(9):2261-2271 (1986).
Holy et al., "3'-0-Phosphonylmethyl-9-(S)-(2,3-dihydroxypropyl) adenine novel type of biologically active nucleotide analogue", Nucl. Acids Res., Symposium Series 14 (1984), pp. 277-278.
Holy et al., "Synthesis and evaluation of acyclic nucleotide analogs", Chemical Abstract, vol. 111:23866m, (1989).
Kim et al., "Acyclic Purine Phosphonate Analogues as Antiviral Agents. Synthesis and Structure--Activity Relationships", J. Med. Chem., vol. 33, (1990), pp. 1207-1213.
Martin et al., "Synthesis and antiherpesvirus activity of (S)-1 ((3-hydroxy-2-phosphonylmethoxy)propyl.)cytosine (HPMPC) and related nucleotide analogues", Nucleosides & Nucleotides, vol. 8(5&6):923-926, (1989).
Prisbe et al., "Synthesis and Antiherpes Virus Activity of Phosphate and Phosphonate Derivatives of 9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine", J. Med Chem. (1986) vol. 29, pp. 671-675.
Rosenberg et al., "Acyclic nucleotide analogs. IV. Phosphonyl methoxyalkyl and phosphonylalkyl derivatives of adenine", Chemical Abstract, vol. 111:174565p, (1989).
Stinson, Stephen C., "Chiral Drugs", C&EN, (Sep. 27, 1993) pp. 38-65.
Webb et al., "Antiviral phosphonomethoxyalkylpurines and -pyrimidines and their preparation", Chemical Abstract, (1988), 109:190136p.
Yang et al, "New Antiretroviral Acyclic Nucleotide Analog: (R)-2'-PMEG ((R)-N(2-phosphonylmethoxypropylguanine)", Antiviral Research, Program & Abstracts of 4th International Conference on Antiviral Research, New Orleans, Apr. 21-26, 1991, Abstract 162 on p. 131.
Balzarini et al, "Differential Antiherpesvirus and Antiretrovirus Effects of the (S) and (R) Enantiomers of Acyclic Nucleoside Phosphonates: Potent and Selective In Vitro and In Vivo Antiretrovirus Activities of (R)-9-(2-Phosphonomethoxypropyl)-2,6-Diaminopurine", Antimicrobial Agents and Chemotherapy, vol. 37, No. 2, pp. 332--338. (1993).
Bronson et al., "Synthesis and Antiviral Activity of Phosphonylmethoxyethyl Derivatives of Purine and Pyrimidine Bases", Nucleotide Analogs as Antiviral Agents, ACS Symposium Series 401 (1989), Chapter 5, pp. 72-87 (Martin, J.C. ed.).
DeClercq et al., "(S)-9-(2,3-dihydroxypropyl)adenine: An Aliphatic Nucleoside Analog with Broad-Spectrum Antiviral Activity", Science (1978), vol. 200, pp. 563-565.
De Clercq et al., "A novel selective broad-spectrum anti-DNA virus agent", Nature, (1986) vol. 323, pp. 464-467.
De Clercq et al., "Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines", Antiviral Research. (1987) vol. 8, pp. 261-272.
Reist et al., "Nucleotide Analogs as Antiviral Agents" ACS Symposium Series, No. 401, (1989) Chapter 2, pp. 17-34.
Tolman et al., "Nucleotide Analogs as Antiviral Agents" ACS Symposium Series, No. 401, (1989) Chapter 3, pp. 34-50.
Prisbe et al., J. Med. Chem. (1986) 29:671-675.
Holy et al., Antiviral Res. (1990) 13:295-312.
Holy et al., Collection Czech. Chem. Commun. (1987) 52:2801-2807.
Holy et al., Collection Czech. Chem. Commun. (1989) 54:2190-2210.
Balzarini et al., AIDS (1991) 5:21-28.
Egberink et al., Proc. Natl. Acad. Sci. (1990) 87:3087-3091.
Holy et al., "Nucleotide Analogs as Antiviral Agents" ACS Symposium Series, No. 401, (1989) pp. 51-71.
Balzarini et al., Proc. Natl. Acad. Sci. (1991) 88:4961-4965.
Rosenberg et al., Collection Czech. Chem. Commun. (1988) 53:2753-2777.
Balzarini Jan Marie Rene
DeClercq Erik Desire Alice
Dvorakova Hana
Holy Antonin
Bernhardt Emily
Hensley Max D.
Institute of Organic Chemistry and Biochemistry of the Academy o
Rega Stichting v.z.w.
LandOfFree
Antiretroviral enantiomeric nucleotide analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antiretroviral enantiomeric nucleotide analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiretroviral enantiomeric nucleotide analogs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1593919